Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -804.37% is 134% below its 5-year average of -343.18%, near the high end of its 5-year range (-157505.13%–57539.25%).
97.17% above its 12-month average of -28446.68%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -1590.42%.
NET PROFIT MARGIN
-804.37%
NET PROFIT MARGIN AVG TTM
-28446.68%
NET PROFIT MARGIN AVG 3Y
-2739.52%
NET PROFIT MARGIN AVG 5Y
-343.18%
NET PROFIT MARGIN AVG 10Y
-74.60%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+97.17%
CURRENT VS 3Y AVG
+70.64%
CURRENT VS 5Y AVG
-134.39%
CURRENT VS 10Y AVG
-978.30%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 727 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Dare Bioscience, Inc.
Market Cap
$12.56M
Net Profit Margin
-804.37%
TTM Avg
-28446.68%
3Y Avg
-2739.52%
5Y Avg
-343.18%
Market Cap
$12.60M
Net Profit Margin
-48.94%
TTM Avg
-40.16%
3Y Avg
-67.25%
5Y Avg
-58.35%
Market Cap
$13.01M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$12.86M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$12.88M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$12.37M
Net Profit Margin
-6.88%
TTM Avg
-8.42%
3Y Avg
-15.06%
5Y Avg
-13.62%
Market Cap
$11.81M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$13.56M
Net Profit Margin
-3972.87%
TTM Avg
-1209.50%
3Y Avg
-3598.61%
5Y Avg
-2399.08%
Market Cap
$11.54M
Net Profit Margin
-2406.00%
TTM Avg
-2017.47%
3Y Avg
-5077.56%
5Y Avg
-6322.50%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dare Bioscience, Inc. (DARE) | $12.56M | -804.37% | -28446.68% | -2739.52% | -343.18% |
| Cytosorbents Corporation (CTSO)vs › | $12.60M | -48.94% | -40.16% | -67.25% | -58.35% |
| Lantern Pharma Inc. (LTRN)vs › | $13.01M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cellectar Biosciences, Inc. (CLRB)vs › | $12.86M | 0.00% | 0.00% | 0.00% | 0.00% |
| Passage Bio, Inc. (PASG)vs › | $12.88M | 0.00% | 0.00% | 0.00% | 0.00% |
| IRIDEX Corporation (IRIX)vs › | $12.37M | -6.88% | -8.42% | -15.06% | -13.62% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.81M | 0.00% | 0.00% | 0.00% | 0.00% |
| Optimi Health Corp. (OPTH)vs › | $13.56M | -3972.87% | -1209.50% | -3598.61% | -2399.08% |
| Pluri Inc. (PLUR)vs › | $11.54M | -2406.00% | -2017.47% | -5077.56% | -6322.50% |
| Phio Pharmaceuticals Corp. (PHIO)vs › | $11.50M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
-1315.5%
Net Profit Margin
-804.4%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -1590.42% |
| 2026-03-31 | -1967.72% |
| 2025-12-31 | -140.84% |
| 2025-09-30 | -157505.13% |
| 2025-06-30 | 18970.73% |
| 2025-03-31 | -17219.13% |
| 2024-12-31 | 8651.47% |
| 2024-09-30 | -11279.42% |
| 2024-06-30 | 57539.25% |
| 2024-03-31 | -72622.62% |
| 2023-12-31 | -279.75% |
| 2023-09-30 | -829.91% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 4.14% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 497.87% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | -644.08% |
| 2017-03-31 | -531.80% |
| 2016-12-31 | -645.56% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | -22433.33% |
| 2014-03-31 | -6200.00% |
| 2013-12-31 | -58000.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |